BSE filing, NSE: VAGHANI. Summary written from the filing by ALFA Finder's alert engine.
Emrock Corporation Ltd: key numbers
- Share price
- ₹228.00
- Market cap
- ₹360.7 Cr
- Revenue (annual)
- ₹2.06 Cr
- Net profit (annual)
- ₹1.21 Cr
- P/E (TTM)
- 293.4×Sector 26.8×
- Promoter holding
- 74.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emrock Corporation Ltd
All →Emrock Corporation Bags New Order from Uttar Gujarat Vij Company Limited
Emrock Corporation received confirmation of PPAs with UGVCL for 12 MW of solar power over 25 years. Total confirmed UGVCL commitments now stand at 40 MW.
- From
- Uttar Gujarat Vij Company Limited (UGVCL)
- Execution
- 25 years PPA tenure; generation expected by March 20, 2028 (one project) and March 23, 2028 (two projects)
- solar capacity
- 12.0 MW
Emrock Corporation Annual General Meeting
Emrock Corporation clarified a typo in its EGM notice, correcting 'infrequently traded' to 'frequently traded' for its shares. No financial impact results from this correction.
Emrock Corporation Management Change
Emrock Corporation Limited has appointed Mrs. Rekha Sejpal as its Secretarial Auditor, effective April 1, 2026.
Emrock Corporation Acquisition Worth ₹0.01 Cr
Emrock Corporation Limited acquired a 50.50% stake in Emrock Lifescience LLP for Rs. 0.00505 Crore as part of its strategic entry into the pharmaceutical sector.
- Value
- ₹0.01 Cr
Emrock Corporation Other Announcement
Emrock Corporation Ltd confirmed that Regulation 57(5) of SEBI (LODR) is not applicable to the Company for the quarter ended 30th September 2026.
Emrock Corporation Annual General Meeting
Emrock Corporation Limited held its 32nd Annual General Meeting on September 29, 2026. Shareholders considered agenda items including financial statements, director reappointment, and related party transactions.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.